📰 Consensus Statement News
Page 6 - Consensus Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Consensus Statement. Real-time updates on events, politics, business and more.
March 30, 2022
Dentists from the University of Sheffield are helping the oral healthcare sector move towards more environmentally friendly practices that will reduce the carbon footprint of the profession.
February 19, 2022
The medicating of preschoolers diagnosed with ADHD is on the rise. A review of research tells of great harm being done.
February 16, 2022
In its May 25, 2021 issue, JAMA published a report on the comparative efficacy of two medications for treating preschoolers diagnosed with ADHD. Both methy
February 2, 2022
Our popular daily links, including flowers in amber, lightning, Alphabet revenues, floors, EU sustainability, China zero Covid, Tonga, Myanmar coup anniversary, Israeli intelligence, Ukraine crisis, the Pentagon, Paycheck Protection Program, the Fed
January 21, 2022
The International Association for Dental Research (IADR) highlighted an article on future directions for the behavioral and social oral health sciences field.
January 20, 2022
The behavioral and social sciences are central to understanding and addressing dental, oral, and craniofacial health, diseases, and conditions, and are relevant to every discipline in dentistry.
January 19, 2022
Alexandria, VA, USA — The behavioral and social sciences are central to understanding and addressing dental, oral, and craniofacial health, diseases
December 15, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating...
December 15, 2021
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating...
December 15, 2021
DUBLIN, Dec. 15, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety